|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:EHHADH-ABCC5 (FusionGDB2 ID:25550) |
Fusion Gene Summary for EHHADH-ABCC5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: EHHADH-ABCC5 | Fusion gene ID: 25550 | Hgene | Tgene | Gene symbol | EHHADH | ABCC5 | Gene ID | 1962 | 10057 |
Gene name | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | ATP binding cassette subfamily C member 5 | |
Synonyms | ECHD|FRTS3|L-PBE|LBFP|LBP|PBFE | ABC33|EST277145|MOAT-C|MOATC|MRP5|SMRP|pABC11 | |
Cytomap | 3q27.2 | 3q27.1 | |
Type of gene | protein-coding | protein-coding | |
Description | peroxisomal bifunctional enzyme3,2-trans-enoyl-CoA isomeraseL-3-hydroxyacyl-CoA dehydrogenaseL-bifunctional protein, peroxisomalPBEenoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenaseenoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase | multidrug resistance-associated protein 5ATP-binding cassette, sub-family C (CFTR/MRP), member 5canalicular multispecific organic anion transporter Cmulti-specific organic anion transporter C | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | Q08426 | O15440 | |
Ensembl transtripts involved in fusion gene | ENST00000231887, ENST00000456310, ENST00000475987, ENST00000440662, | ENST00000334444, ENST00000265586, ENST00000492216, ENST00000427120, ENST00000392579, ENST00000382494, ENST00000446941, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 6 X 7 X 6=252 |
# samples | 2 | 9 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(9/252*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EHHADH [Title/Abstract] AND ABCC5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EHHADH(184922204)-ABCC5(183696439), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | EHHADH-ABCC5 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. EHHADH-ABCC5 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. EHHADH-ABCC5 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EHHADH | GO:0006475 | internal protein amino acid acetylation | 20167786 |
Tgene | ABCC5 | GO:0042908 | xenobiotic transport | 10840050 |
Tgene | ABCC5 | GO:0140115 | export across plasma membrane | 10840050 |
Fusion gene breakpoints across EHHADH (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ABCC5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-D8-A27N-01A | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
ChimerDB4 | BRCA | TCGA-D8-A27N-01A | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
Top |
Fusion Gene ORF analysis for EHHADH-ABCC5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000231887 | ENST00000334444 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
In-frame | ENST00000231887 | ENST00000265586 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-5UTR | ENST00000231887 | ENST00000492216 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000231887 | ENST00000427120 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000231887 | ENST00000392579 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000231887 | ENST00000382494 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000231887 | ENST00000446941 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
Frame-shift | ENST00000456310 | ENST00000334444 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
Frame-shift | ENST00000456310 | ENST00000265586 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-5UTR | ENST00000456310 | ENST00000492216 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000456310 | ENST00000427120 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000456310 | ENST00000392579 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000456310 | ENST00000382494 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
5CDS-intron | ENST00000456310 | ENST00000446941 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-3CDS | ENST00000475987 | ENST00000334444 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-3CDS | ENST00000475987 | ENST00000265586 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-5UTR | ENST00000475987 | ENST00000492216 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000475987 | ENST00000427120 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000475987 | ENST00000392579 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000475987 | ENST00000382494 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000475987 | ENST00000446941 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-3CDS | ENST00000440662 | ENST00000334444 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-3CDS | ENST00000440662 | ENST00000265586 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-5UTR | ENST00000440662 | ENST00000492216 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000440662 | ENST00000427120 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000440662 | ENST00000392579 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000440662 | ENST00000382494 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
intron-intron | ENST00000440662 | ENST00000446941 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000231887 | EHHADH | chr3 | 184922204 | - | ENST00000334444 | ABCC5 | chr3 | 183696439 | - | 5519 | 986 | 34 | 4152 | 1372 |
ENST00000231887 | EHHADH | chr3 | 184922204 | - | ENST00000265586 | ABCC5 | chr3 | 183696439 | - | 4110 | 986 | 34 | 4023 | 1329 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000231887 | ENST00000334444 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - | 0.00083297 | 0.9991671 |
ENST00000231887 | ENST00000265586 | EHHADH | chr3 | 184922204 | - | ABCC5 | chr3 | 183696439 | - | 0.002356549 | 0.9976434 |
Top |
Fusion Genomic Features for EHHADH-ABCC5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EHHADH-ABCC5 |
Go to FGviewer for the breakpoints of chr3:184922204-chr3:183696439 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
EHHADH | ABCC5 |
FUNCTION: Peroxisomal trifunctional enzyme possessing 2-enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and delta 3, delta 2-enoyl-CoA isomerase activities. Catalyzes two of the four reactions of the long straight chain fatty acids peroxisomal beta-oxidation pathway. Optimal isomerase for 2,5 double bonds into 3,5 form isomerization in a range of enoyl-CoA species (Probable). Also able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species (By similarity). With HSD17B4, catalyzes the hydration of trans-2-enoyl-CoA and the dehydrogenation of 3-hydroxyacyl-CoA, but with opposite chiral specificity (PubMed:15060085). Regulates the amount of medium-chain dicarboxylic fatty acids which are essential regulators of all fatty acid oxidation pathways (By similarity). Also involved in the degradation of long-chain dicarboxylic acids through peroxisomal beta-oxidation (PubMed:15060085). {ECO:0000250|UniProtKB:P07896, ECO:0000250|UniProtKB:Q9DBM2, ECO:0000269|PubMed:15060085, ECO:0000305|PubMed:15060085}. | FUNCTION: Acts as a multispecific organic anion pump which can transport nucleotide analogs. Heme transporter required for the translocation of cytosolic heme to the secretory pathway (PubMed:24836561). {ECO:0000269|PubMed:10840050, ECO:0000269|PubMed:24836561}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EHHADH | chr3:184922204 | chr3:183696439 | ENST00000231887 | - | 6 | 7 | 1_282 | 303.3333333333333 | 724.0 | Region | Note=Enoyl-CoA hydratase / isomerase |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 1193_1427 | 382.3333333333333 | 1438.0 | Domain | ABC transporter 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 562_783 | 382.3333333333333 | 1438.0 | Domain | ABC transporter 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 859_1155 | 382.3333333333333 | 1438.0 | Domain | ABC transmembrane type-1 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 1193_1427 | 0 | 533.3333333333334 | Domain | ABC transporter 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 179_459 | 0 | 533.3333333333334 | Domain | ABC transmembrane type-1 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 562_783 | 0 | 533.3333333333334 | Domain | ABC transporter 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 859_1155 | 0 | 533.3333333333334 | Domain | ABC transmembrane type-1 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 1193_1427 | 0 | 226.0 | Domain | ABC transporter 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 179_459 | 0 | 226.0 | Domain | ABC transmembrane type-1 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 562_783 | 0 | 226.0 | Domain | ABC transporter 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 859_1155 | 0 | 226.0 | Domain | ABC transmembrane type-1 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 1227_1234 | 382.3333333333333 | 1438.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 595_602 | 382.3333333333333 | 1438.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 1227_1234 | 0 | 533.3333333333334 | Nucleotide binding | ATP 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 595_602 | 0 | 533.3333333333334 | Nucleotide binding | ATP 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 1227_1234 | 0 | 226.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 595_602 | 0 | 226.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 1018_1038 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 1104_1124 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 1127_1147 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 400_420 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 434_454 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 608_628 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 848_868 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 917_937 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 997_1017 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 1018_1038 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 1104_1124 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 1127_1147 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 179_199 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 219_239 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 296_316 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 317_337 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 400_420 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 434_454 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 608_628 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 848_868 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 917_937 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000382494 | 0 | 7 | 997_1017 | 0 | 533.3333333333334 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 1018_1038 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 1104_1124 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 1127_1147 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 179_199 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 219_239 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 296_316 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 317_337 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 400_420 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 434_454 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 608_628 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 848_868 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 917_937 | 0 | 226.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000392579 | 0 | 6 | 997_1017 | 0 | 226.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EHHADH | chr3:184922204 | chr3:183696439 | ENST00000231887 | - | 6 | 7 | 721_723 | 303.3333333333333 | 724.0 | Motif | Note=Microbody targeting signal |
Hgene | EHHADH | chr3:184922204 | chr3:183696439 | ENST00000456310 | - | 6 | 7 | 721_723 | 207.33333333333334 | 628.0 | Motif | Note=Microbody targeting signal |
Hgene | EHHADH | chr3:184922204 | chr3:183696439 | ENST00000231887 | - | 6 | 7 | 283_572 | 303.3333333333333 | 724.0 | Region | Note=3-hydroxyacyl-CoA dehydrogenase |
Hgene | EHHADH | chr3:184922204 | chr3:183696439 | ENST00000456310 | - | 6 | 7 | 1_282 | 207.33333333333334 | 628.0 | Region | Note=Enoyl-CoA hydratase / isomerase |
Hgene | EHHADH | chr3:184922204 | chr3:183696439 | ENST00000456310 | - | 6 | 7 | 283_572 | 207.33333333333334 | 628.0 | Region | Note=3-hydroxyacyl-CoA dehydrogenase |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 179_459 | 382.3333333333333 | 1438.0 | Domain | ABC transmembrane type-1 1 | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 179_199 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 219_239 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 296_316 | 382.3333333333333 | 1438.0 | Transmembrane | Helical | |
Tgene | ABCC5 | chr3:184922204 | chr3:183696439 | ENST00000334444 | 7 | 30 | 317_337 | 382.3333333333333 | 1438.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for EHHADH-ABCC5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000231887_ENST00000334444_TCGA-D8-A27N-01A_EHHADH_chr3_184922204_-_ABCC5_chr3_183696439_length(transcript)=5519nt_BP=986nt GAGGAGGCCGGGCGCGCCCGGAAAAGTGGTTTGCCTGACGGCGAGAGGCAGAGGTGCCCTCGGTGATAGAGGAAACATGGCCGAGTATAC GCGGCTGCACAACGCCTTGGCGCTAATCCGCCTCCGAAACCCGCCGGTCAACGCGATCAGTACGACTTTACTCCGTGACATAAAAGAAGG ACTACAGAAAGCTGTAATAGACCATACAATAAAAGCCATTGTGATTTGTGGAGCAGAGGGCAAATTTTCTGCAGGTGCTGATATTCGTGG CTTCAGTGCTCCTAGGACATTTGGCCTTACACTGGGACATGTAGTAGATGAAATACAGAGAAATGAGAAGCCCGTGGTGGCAGCAATCCA AGGCATGGCTTTCGGAGGGGGACTAGAGCTGGCCCTGGGCTGTCACTATAGGATTGCCCACGCAGAGGCTCAAGTTGGCTTACCAGAAGT TACACTGGGACTTCTCCCTGGTGCAAGAGGAACCCAGCTTCTCCCCAGACTCACTGGAGTTCCTGCTGCACTTGACTTAATTACCTCAGG AAGACGTATTTTAGCAGATGAAGCACTCAAGCTGGGCATTCTAGATAAAGTTGTAAACTCAGACCCGGTTGAAGAAGCAATCAGATTTGC TCAGAGAGTTTCAGATCAACCTCTAGAATCCCGTAGACTCTGCAACAAGCCAATTCAGAGCTTGCCCAACATGGACAGCATTTTTAGTGA GGCCCTCTTGAAGATGCGGAGGCAGCACCCTGGGTGTCTTGCACAGGAGGCTTGTGTCCGTGCAGTCCAGGCTGCTGTGCAGTATCCCTA TGAAGTGGGCATCAAGAAGGAGGAGGAGCTGTTTCTATATCTTTTGCAATCAGGGCAGGCTAGAGCCCTGCAATATGCTTTCTTCGCTGA AAGGAAAGCAAATAAGTGGTCAACTCCCTCCGGAGCATCGTGGAAAACAGCATCAGCGCGGCCTGTCTCCTCAGTTGGTGTTGTTGAAAT CCGCGAGGAGGAGCGTCGGATATTGGAAAAAGCTGGGTACTTCCAGAGCATCACTGTGGGTGTGGCTCCCATTGTGGTGGTGATTGCCAG CGTGGTGACCTTCTCTGTTCATATGACCCTGGGCTTCGATCTGACAGCAGCACAGGCTTTCACAGTGGTGACAGTCTTCAATTCCATGAC TTTTGCTTTGAAAGTAACACCGTTTTCAGTAAAGTCCCTCTCAGAAGCCTCAGTGGCTGTTGACAGATTTAAGAGTTTGTTTCTAATGGA AGAGGTTCACATGATAAAGAACAAACCAGCCAGTCCTCACATCAAGATAGAGATGAAAAATGCCACCTTGGCATGGGACTCCTCCCACTC CAGTATCCAGAACTCGCCCAAGCTGACCCCCAAAATGAAAAAAGACAAGAGGGCTTCCAGGGGCAAGAAAGAGAAGGTGAGGCAGCTGCA GCGCACTGAGCATCAGGCGGTGCTGGCAGAGCAGAAAGGCCACCTCCTCCTGGACAGTGACGAGCGGCCCAGTCCCGAAGAGGAAGAAGG CAAGCACATCCACCTGGGCCACCTGCGCTTACAGAGGACACTGCACAGCATCGATCTGGAGATCCAAGAGGGTAAACTGGTTGGAATCTG TGGCAGTGTGGGAAGTGGAAAAACCTCTCTCATTTCAGCCATTTTAGGCCAGATGACGCTTCTAGAGGGCAGCATTGCAATCAGTGGAAC CTTCGCTTATGTGGCCCAGCAGGCCTGGATCCTCAATGCTACTCTGAGAGACAACATCCTGTTTGGGAAGGAATATGATGAAGAAAGATA CAACTCTGTGCTGAACAGCTGCTGCCTGAGGCCTGACCTGGCCATTCTTCCCAGCAGCGACCTGACGGAGATTGGAGAGCGAGGAGCCAA CCTGAGCGGTGGGCAGCGCCAGAGGATCAGCCTTGCCCGGGCCTTGTATAGTGACAGGAGCATCTACATCCTGGACGACCCCCTCAGTGC CTTAGATGCCCATGTGGGCAACCACATCTTCAATAGTGCTATCCGGAAACATCTCAAGTCCAAGACAGTTCTGTTTGTTACCCACCAGTT ACAGTACCTGGTTGACTGTGATGAAGTGATCTTCATGAAAGAGGGCTGTATTACGGAAAGAGGCACCCATGAGGAACTGATGAATTTAAA TGGTGACTATGCTACCATTTTTAATAACCTGTTGCTGGGAGAGACACCGCCAGTTGAGATCAATTCAAAAAAGGAAACCAGTGGTTCACA GAAGAAGTCACAAGACAAGGGTCCTAAAACAGGATCAGTAAAGAAGGAAAAAGCAGTAAAGCCAGAGGAAGGGCAGCTTGTGCAGCTGGA AGAGAAAGGGCAGGGTTCAGTGCCCTGGTCAGTATATGGTGTCTACATCCAGGCTGCTGGGGGCCCCTTGGCATTCCTGGTTATTATGGC CCTTTTCATGCTGAATGTAGGCAGCACCGCCTTCAGCACCTGGTGGTTGAGTTACTGGATCAAGCAAGGAAGCGGGAACACCACTGTGAC TCGAGGGAACGAGACCTCGGTGAGTGACAGCATGAAGGACAATCCTCATATGCAGTACTATGCCAGCATCTACGCCCTCTCCATGGCAGT CATGCTGATCCTGAAAGCCATTCGAGGAGTTGTCTTTGTCAAGGGCACGCTGCGAGCTTCCTCCCGGCTGCATGACGAGCTTTTCCGAAG GATCCTTCGAAGCCCTATGAAGTTTTTTGACACGACCCCCACAGGGAGGATTCTCAACAGGTTTTCCAAAGACATGGATGAAGTTGACGT GCGGCTGCCGTTCCAGGCCGAGATGTTCATCCAGAACGTTATCCTGGTGTTCTTCTGTGTGGGAATGATCGCAGGAGTCTTCCCGTGGTT CCTTGTGGCAGTGGGGCCCCTTGTCATCCTCTTTTCAGTCCTGCACATTGTCTCCAGGGTCCTGATTCGGGAGCTGAAGCGTCTGGACAA TATCACGCAGTCACCTTTCCTCTCCCACATCACGTCCAGCATACAGGGCCTTGCCACCATCCACGCCTACAATAAAGGGCAGGAGTTTCT GCACAGATACCAGGAGCTGCTGGATGACAACCAAGCTCCTTTTTTTTTGTTTACGTGTGCGATGCGGTGGCTGGCTGTGCGGCTGGACCT CATCAGCATCGCCCTCATCACCACCACGGGGCTGATGATCGTTCTTATGCACGGGCAGATTCCCCCAGCCTATGCGGGTCTCGCCATCTC TTATGCTGTCCAGTTAACGGGGCTGTTCCAGTTTACGGTCAGACTGGCATCTGAGACAGAAGCTCGATTCACCTCGGTGGAGAGGATCAA TCACTACATTAAGACTCTGTCCTTGGAAGCACCTGCCAGAATTAAGAACAAGGCTCCCTCCCCTGACTGGCCCCAGGAGGGAGAGGTGAC CTTTGAGAACGCAGAGATGAGGTACCGAGAAAACCTCCCTCTCGTCCTAAAGAAAGTATCCTTCACGATCAAACCTAAAGAGAAGATTGG CATTGTGGGGCGGACAGGATCAGGGAAGTCCTCGCTGGGGATGGCCCTCTTCCGTCTGGTGGAGTTATCTGGAGGCTGCATCAAGATTGA TGGAGTGAGAATCAGTGATATTGGCCTTGCCGACCTCCGAAGCAAACTCTCTATCATTCCTCAAGAGCCGGTGCTGTTCAGTGGCACTGT CAGATCAAATTTGGACCCCTTCAACCAGTACACTGAAGACCAGATTTGGGATGCCCTGGAGAGGACACACATGAAAGAATGTATTGCTCA GCTACCTCTGAAACTTGAATCTGAAGTGATGGAGAATGGGGATAACTTCTCAGTGGGGGAACGGCAGCTCTTGTGCATAGCTAGAGCCCT GCTCCGCCACTGTAAGATTCTGATTTTAGATGAAGCCACAGCTGCCATGGACACAGAGACAGACTTATTGATTCAAGAGACCATCCGAGA AGCATTTGCAGACTGTACCATGCTGACCATTGCCCATCGCCTGCACACGGTTCTAGGCTCCGATAGGATTATGGTGCTGGCCCAGGGACA GGTGGTGGAGTTTGACACCCCATCGGTCCTTCTGTCCAACGACAGTTCCCGATTCTATGCCATGTTTGCTGCTGCAGAGAACAAGGTCGC TGTCAAGGGCTGACTCCTCCCTGTTGACGAAGTCTCTTTTCTTTAGAGCATTGCCATTCCCTGCCTGGGGCGGGCCCCTCATCGCGTCCT CCTACCGAAACCTTGCCTTTCTCGATTTTATCTTTCGCACAGCAGTTCCGGATTGGCTTGTGTGTTTCACTTTTAGGGAGAGTCATATTT TGATTATTGTATTTATTCCATATTCATGTAAACAAAATTTAGTTTTTGTTCTTAATTGCACTCTAAAAGGTTCAGGGAACCGTTATTATA ATTGTATCAGAGGCCTATAATGAAGCTTTATACGTGTAGCTATATCTATATATAATTCTGTACATAGCCTATATTTACAGTGAAAATGTA AGCTGTTTATTTTATATTAAAATAAGCACTGTGCTAATAACAGTGCATATTCCTTTCTATCATTTTTGTACAGTTTGCTGTACTAGAGAT CTGGTTTTGCTATTAGACTGTAGGAAGAGTAGCATTTCATTCTTCTCTAGCTGGTGGTTTCACGGTGCCAGGTTTTCTGGGTGTCCAAAG GAAGACGTGTGGCAATAGTGGGCCCTCCGACAGCCCCCTCTGCCGCCTCCCCACGGCCGCTCCAGGGGTGGCTGGAGACGGGTGGGCGGC TGGAGACCATGCAGAGCGCCGTGAGTTCTCAGGGCTCCTGCCTTCTGTCCTGGTGTCACTTACTGTTTCTGTCAGGAGAGCAGCGGGGCG AAGCCCAGGCCCCTTTTCACTCCCTCCATCAAGAATGGGGATCACAGAGACATTCCTCCGAGCCGGGGAGTTTCTTTCCTGCCTTCTTCT TTTTGCTGTTGTTTCTAAACAAGAATCAGTCTATCCACAGAGAGTCCCACTGCCTCAGGTTCCTATGGCTGGCCACTGCACAGAGCTCTC CAGCTCCAAGACCTGTTGGTTCCAAGCCCTGGAGCCAACTGCTGCTTTTTGAGGTGGCACTTTTTCATTTGCCTATTCCCACACCTCCAC AGTTCAGTGGCAGGGCTCAGGATTTCGTGGGTCTGTTTTCCTTTCTCACCGCAGTCGTCGCACAGTCTCTCTCTCTCTCTCCCCTCAAAG TCTGCAACTTTAAGCAGCTCTTGCTAATCAGTGTCTCACACTGGCGTAGAAGTTTTTGTACTGTAAAGAGACCTACCTCAGGTTGCTGGT TGCTGTGTGGTTTGGTGTGTTCCCGCAAACCCCCTTTGTGCTGTGGGGCTGGTAGCTCAGGTGGGCGTGGTCACTGCTGTCATCAATTGA ATGGTCAGCGTTGCATGTCGTGACCAACTAGACATTCTGTCGCCTTAGCATGTTTGCTGAACACCTTGTGGAAGCAAAAATCTGAAAATG >In-frame_ENST00000231887_ENST00000334444_TCGA-D8-A27N-01A_EHHADH_chr3_184922204_-_ABCC5_chr3_183696439_length(amino acids)=1372AA_start in transcript=34_stop in transcript=4152 MTARGRGALGDRGNMAEYTRLHNALALIRLRNPPVNAISTTLLRDIKEGLQKAVIDHTIKAIVICGAEGKFSAGADIRGFSAPRTFGLTL GHVVDEIQRNEKPVVAAIQGMAFGGGLELALGCHYRIAHAEAQVGLPEVTLGLLPGARGTQLLPRLTGVPAALDLITSGRRILADEALKL GILDKVVNSDPVEEAIRFAQRVSDQPLESRRLCNKPIQSLPNMDSIFSEALLKMRRQHPGCLAQEACVRAVQAAVQYPYEVGIKKEEELF LYLLQSGQARALQYAFFAERKANKWSTPSGASWKTASARPVSSVGVVEIREEERRILEKAGYFQSITVGVAPIVVVIASVVTFSVHMTLG FDLTAAQAFTVVTVFNSMTFALKVTPFSVKSLSEASVAVDRFKSLFLMEEVHMIKNKPASPHIKIEMKNATLAWDSSHSSIQNSPKLTPK MKKDKRASRGKKEKVRQLQRTEHQAVLAEQKGHLLLDSDERPSPEEEEGKHIHLGHLRLQRTLHSIDLEIQEGKLVGICGSVGSGKTSLI SAILGQMTLLEGSIAISGTFAYVAQQAWILNATLRDNILFGKEYDEERYNSVLNSCCLRPDLAILPSSDLTEIGERGANLSGGQRQRISL ARALYSDRSIYILDDPLSALDAHVGNHIFNSAIRKHLKSKTVLFVTHQLQYLVDCDEVIFMKEGCITERGTHEELMNLNGDYATIFNNLL LGETPPVEINSKKETSGSQKKSQDKGPKTGSVKKEKAVKPEEGQLVQLEEKGQGSVPWSVYGVYIQAAGGPLAFLVIMALFMLNVGSTAF STWWLSYWIKQGSGNTTVTRGNETSVSDSMKDNPHMQYYASIYALSMAVMLILKAIRGVVFVKGTLRASSRLHDELFRRILRSPMKFFDT TPTGRILNRFSKDMDEVDVRLPFQAEMFIQNVILVFFCVGMIAGVFPWFLVAVGPLVILFSVLHIVSRVLIRELKRLDNITQSPFLSHIT SSIQGLATIHAYNKGQEFLHRYQELLDDNQAPFFLFTCAMRWLAVRLDLISIALITTTGLMIVLMHGQIPPAYAGLAISYAVQLTGLFQF TVRLASETEARFTSVERINHYIKTLSLEAPARIKNKAPSPDWPQEGEVTFENAEMRYRENLPLVLKKVSFTIKPKEKIGIVGRTGSGKSS LGMALFRLVELSGGCIKIDGVRISDIGLADLRSKLSIIPQEPVLFSGTVRSNLDPFNQYTEDQIWDALERTHMKECIAQLPLKLESEVME NGDNFSVGERQLLCIARALLRHCKILILDEATAAMDTETDLLIQETIREAFADCTMLTIAHRLHTVLGSDRIMVLAQGQVVEFDTPSVLL -------------------------------------------------------------- >In-frame_ENST00000231887_ENST00000265586_TCGA-D8-A27N-01A_EHHADH_chr3_184922204_-_ABCC5_chr3_183696439_length(transcript)=4110nt_BP=986nt GAGGAGGCCGGGCGCGCCCGGAAAAGTGGTTTGCCTGACGGCGAGAGGCAGAGGTGCCCTCGGTGATAGAGGAAACATGGCCGAGTATAC GCGGCTGCACAACGCCTTGGCGCTAATCCGCCTCCGAAACCCGCCGGTCAACGCGATCAGTACGACTTTACTCCGTGACATAAAAGAAGG ACTACAGAAAGCTGTAATAGACCATACAATAAAAGCCATTGTGATTTGTGGAGCAGAGGGCAAATTTTCTGCAGGTGCTGATATTCGTGG CTTCAGTGCTCCTAGGACATTTGGCCTTACACTGGGACATGTAGTAGATGAAATACAGAGAAATGAGAAGCCCGTGGTGGCAGCAATCCA AGGCATGGCTTTCGGAGGGGGACTAGAGCTGGCCCTGGGCTGTCACTATAGGATTGCCCACGCAGAGGCTCAAGTTGGCTTACCAGAAGT TACACTGGGACTTCTCCCTGGTGCAAGAGGAACCCAGCTTCTCCCCAGACTCACTGGAGTTCCTGCTGCACTTGACTTAATTACCTCAGG AAGACGTATTTTAGCAGATGAAGCACTCAAGCTGGGCATTCTAGATAAAGTTGTAAACTCAGACCCGGTTGAAGAAGCAATCAGATTTGC TCAGAGAGTTTCAGATCAACCTCTAGAATCCCGTAGACTCTGCAACAAGCCAATTCAGAGCTTGCCCAACATGGACAGCATTTTTAGTGA GGCCCTCTTGAAGATGCGGAGGCAGCACCCTGGGTGTCTTGCACAGGAGGCTTGTGTCCGTGCAGTCCAGGCTGCTGTGCAGTATCCCTA TGAAGTGGGCATCAAGAAGGAGGAGGAGCTGTTTCTATATCTTTTGCAATCAGGGCAGGCTAGAGCCCTGCAATATGCTTTCTTCGCTGA AAGGAAAGCAAATAAGTGGTCAACTCCCTCCGGAGCATCGTGGAAAACAGCATCAGCGCGGCCTGTCTCCTCAGTTGGTGTTGTTGAAAT CCGCGAGGAGGAGCGTCGGATATTGGAAAAAGCTGGGTACTTCCAGAGCATCACTGTGGGTGTGGCTCCCATTGTGGTGGTGATTGCCAG CGTGGTGACCTTCTCTGTTCATATGACCCTGGGCTTCGATCTGACAGCAGCACAGGCTTTCACAGTGGTGACAGTCTTCAATTCCATGAC TTTTGCTTTGAAAGTAACACCGTTTTCAGTAAAGTCCCTCTCAGAAGCCTCAGTGGCTGTTGACAGATTTAAGAGTTTGTTTCTAATGGA AGAGGTTCACATGATAAAGAACAAACCAGCCAGTCCTCACATCAAGATAGAGATGAAAAATGCCACCTTGGCATGGGACTCCTCCCACTC CAGTATCCAGAACTCGCCCAAGCTGACCCCCAAAATGAAAAAAGACAAGAGGGCTTCCAGGGGCAAGAAAGAGAAGGTGAGGCAGCTGCA GCGCACTGAGCATCAGGCGGTGCTGGCAGAGCAGAAAGGCCACCTCCTCCTGGACAGTGACGAGCGGCCCAGTCCCGAAGAGGAAGAAGG CAAGCACATCCACCTGGGCCACCTGCGCTTACAGAGGACACTGCACAGCATCGATCTGGAGATCCAAGAGGGTAAACTGGTTGGAATCTG TGGCAGTGTGGGAAGTGGAAAAACCTCTCTCATTTCAGCCATTTTAGGCCAGATGACGCTTCTAGAGGGCAGCATTGCAATCAGTGGAAC CTTCGCTTATGTGGCCCAGCAGGCCTGGATCCTCAATGCTACTCTGAGAGACAACATCCTGTTTGGGAAGGAATATGATGAAGAAAGATA CAACTCTGTGCTGAACAGCTGCTGCCTGAGGCCTGACCTGGCCATTCTTCCCAGCAGCGACCTGACGGAGATTGGAGAGCGAGGAGCCAA CCTGAGCGGTGGGCAGCGCCAGAGGATCAGCCTTGCCCGGGCCTTGTATAGTGACAGGAGCATCTACATCCTGGACGACCCCCTCAGTGC CTTAGATGCCCATGTGGGCAACCACATCTTCAATAGTGCTATCCGGAAACATCTCAAGTCCAAGACAGTTCTGTTTGTTACCCACCAGTT ACAGTACCTGGTTGACTGTGATGAAGTGATCTTCATGAAAGAGGGCTGTATTACGGAAAGAGGCACCCATGAGGAACTGATGAATTTAAA TGGTGACTATGCTACCATTTTTAATAACCTGTTGCTGGGAGAGACACCGCCAGTTGAGATCAATTCAAAAAAGGAAACCAGTGGTTCACA GAAGAAGTCACAAGACAAGGGTCCTAAAACAGGATCAGTAAAGAAGGAAAAAGCAGTAAAGCCAGAGGAAGGGCAGCTTGTGCAGCTGGA AGAGAAAGGGCAGGGTTCAGTGCCCTGGTCAGTATATGGTGTCTACATCCAGGCTGCTGGGGGCCCCTTGGCATTCCTGGTTATTATGGC CCTTTTCATGCTGAATGTAGGCAGCACCGCCTTCAGCACCTGGTGGTTGAGTTACTGGATCAAGCAAGGAAGCGGGAACACCACTGTGAC TCGAGGGAACGAGACCTCGGTGAGTGACAGCATGAAGGACAATCCTCATATGCAGTACTATGCCAGCATCTACGCCCTCTCCATGGCAGT CATGCTGATCCTGAAAGCCATTCGAGGAGTTGTCTTTGTCAAGGGCACGCTGCGAGCTTCCTCCCGGCTGCATGACGAGCTTTTCCGAAG GATCCTTCGAAGCCCTATGAAGTTTTTTGACACGACCCCCACAGGGAGGATTCTCAACAGGTTTTCCAAAGACATGGATGAAGTTGACGT GCGGCTGCCGTTCCAGGCCGAGATGTTCATCCAGAACGTTATCCTGGTGTTCTTCTGTGTGGGAATGATCGCAGGAGTCTTCCCGTGGTT CCTTGTGGCAGTGGGGCCCCTTGTCATCCTCTTTTCAGTCCTGCACATTGTCTCCAGATACCAGGAGCTGCTGGATGACAACCAAGCTCC TTTTTTTTTGTTTACGTGTGCGATGCGGTGGCTGGCTGTGCGGCTGGACCTCATCAGCATCGCCCTCATCACCACCACGGGGCTGATGAT CGTTCTTATGCACGGGCAGATTCCCCCAGCCTATGCGGGTCTCGCCATCTCTTATGCTGTCCAGTTAACGGGGCTGTTCCAGTTTACGGT CAGACTGGCATCTGAGACAGAAGCTCGATTCACCTCGGTGGAGAGGATCAATCACTACATTAAGACTCTGTCCTTGGAAGCACCTGCCAG AATTAAGAACAAGGCTCCCTCCCCTGACTGGCCCCAGGAGGGAGAGGTGACCTTTGAGAACGCAGAGATGAGGTACCGAGAAAACCTCCC TCTCGTCCTAAAGAAAGTATCCTTCACGATCAAACCTAAAGAGAAGATTGGCATTGTGGGGCGGACAGGATCAGGGAAGTCCTCGCTGGG GATGGCCCTCTTCCGTCTGGTGGAGTTATCTGGAGGCTGCATCAAGATTGATGGAGTGAGAATCAGTGATATTGGCCTTGCCGACCTCCG AAGCAAACTCTCTATCATTCCTCAAGAGCCGGTGCTGTTCAGTGGCACTGTCAGATCAAATTTGGACCCCTTCAACCAGTACACTGAAGA CCAGATTTGGGATGCCCTGGAGAGGACACACATGAAAGAATGTATTGCTCAGCTACCTCTGAAACTTGAATCTGAAGTGATGGAGAATGG GGATAACTTCTCAGTGGGGGAACGGCAGCTCTTGTGCATAGCTAGAGCCCTGCTCCGCCACTGTAAGATTCTGATTTTAGATGAAGCCAC AGCTGCCATGGACACAGAGACAGACTTATTGATTCAAGAGACCATCCGAGAAGCATTTGCAGACTGTACCATGCTGACCATTGCCCATCG CCTGCACACGGTTCTAGGCTCCGATAGGATTATGGTGCTGGCCCAGGGACAGGTGGTGGAGTTTGACACCCCATCGGTCCTTCTGTCCAA CGACAGTTCCCGATTCTATGCCATGTTTGCTGCTGCAGAGAACAAGGTCGCTGTCAAGGGCTGACTCCTCCCTGTTGACGAAGTCTCTTT >In-frame_ENST00000231887_ENST00000265586_TCGA-D8-A27N-01A_EHHADH_chr3_184922204_-_ABCC5_chr3_183696439_length(amino acids)=1329AA_start in transcript=34_stop in transcript=4023 MTARGRGALGDRGNMAEYTRLHNALALIRLRNPPVNAISTTLLRDIKEGLQKAVIDHTIKAIVICGAEGKFSAGADIRGFSAPRTFGLTL GHVVDEIQRNEKPVVAAIQGMAFGGGLELALGCHYRIAHAEAQVGLPEVTLGLLPGARGTQLLPRLTGVPAALDLITSGRRILADEALKL GILDKVVNSDPVEEAIRFAQRVSDQPLESRRLCNKPIQSLPNMDSIFSEALLKMRRQHPGCLAQEACVRAVQAAVQYPYEVGIKKEEELF LYLLQSGQARALQYAFFAERKANKWSTPSGASWKTASARPVSSVGVVEIREEERRILEKAGYFQSITVGVAPIVVVIASVVTFSVHMTLG FDLTAAQAFTVVTVFNSMTFALKVTPFSVKSLSEASVAVDRFKSLFLMEEVHMIKNKPASPHIKIEMKNATLAWDSSHSSIQNSPKLTPK MKKDKRASRGKKEKVRQLQRTEHQAVLAEQKGHLLLDSDERPSPEEEEGKHIHLGHLRLQRTLHSIDLEIQEGKLVGICGSVGSGKTSLI SAILGQMTLLEGSIAISGTFAYVAQQAWILNATLRDNILFGKEYDEERYNSVLNSCCLRPDLAILPSSDLTEIGERGANLSGGQRQRISL ARALYSDRSIYILDDPLSALDAHVGNHIFNSAIRKHLKSKTVLFVTHQLQYLVDCDEVIFMKEGCITERGTHEELMNLNGDYATIFNNLL LGETPPVEINSKKETSGSQKKSQDKGPKTGSVKKEKAVKPEEGQLVQLEEKGQGSVPWSVYGVYIQAAGGPLAFLVIMALFMLNVGSTAF STWWLSYWIKQGSGNTTVTRGNETSVSDSMKDNPHMQYYASIYALSMAVMLILKAIRGVVFVKGTLRASSRLHDELFRRILRSPMKFFDT TPTGRILNRFSKDMDEVDVRLPFQAEMFIQNVILVFFCVGMIAGVFPWFLVAVGPLVILFSVLHIVSRYQELLDDNQAPFFLFTCAMRWL AVRLDLISIALITTTGLMIVLMHGQIPPAYAGLAISYAVQLTGLFQFTVRLASETEARFTSVERINHYIKTLSLEAPARIKNKAPSPDWP QEGEVTFENAEMRYRENLPLVLKKVSFTIKPKEKIGIVGRTGSGKSSLGMALFRLVELSGGCIKIDGVRISDIGLADLRSKLSIIPQEPV LFSGTVRSNLDPFNQYTEDQIWDALERTHMKECIAQLPLKLESEVMENGDNFSVGERQLLCIARALLRHCKILILDEATAAMDTETDLLI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EHHADH-ABCC5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EHHADH-ABCC5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | EHHADH | Q08426 | DB00157 | NADH | Small molecule | Approved|Nutraceutical | |
Hgene | EHHADH | Q08426 | DB00157 | NADH | Small molecule | Approved|Nutraceutical | |
Tgene | ABCC5 | O15440 | DB11672 | Curcumin | Inhibitor | Small molecule | Approved|Experimental|Investigational |
Tgene | ABCC5 | O15440 | DB11672 | Curcumin | Inhibitor | Small molecule | Approved|Experimental|Investigational |
Top |
Related Diseases for EHHADH-ABCC5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EHHADH | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | EHHADH | C0013146 | Drug abuse | 1 | CTD_human |
Hgene | EHHADH | C0013170 | Drug habituation | 1 | CTD_human |
Hgene | EHHADH | C0013222 | Drug Use Disorders | 1 | CTD_human |
Hgene | EHHADH | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Hgene | EHHADH | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | EHHADH | C0038580 | Substance Dependence | 1 | CTD_human |
Hgene | EHHADH | C0038586 | Substance Use Disorders | 1 | CTD_human |
Hgene | EHHADH | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Hgene | EHHADH | C0341703 | Adult Fanconi syndrome | 1 | CTD_human;ORPHANET |
Hgene | EHHADH | C0342870 | Bifunctional peroxisomal enzyme deficiency | 1 | ORPHANET |
Hgene | EHHADH | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | EHHADH | C0740858 | Substance abuse problem | 1 | CTD_human |
Hgene | EHHADH | C1510472 | Drug Dependence | 1 | CTD_human |
Hgene | EHHADH | C3810100 | FANCONI RENOTUBULAR SYNDROME 3 | 1 | GENOMICS_ENGLAND;UNIPROT |
Hgene | EHHADH | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
Hgene | EHHADH | C4551503 | FANCONI RENOTUBULAR SYNDROME 1 | 1 | ORPHANET |
Tgene | ABCC5 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | ABCC5 | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Tgene | ABCC5 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Tgene | ABCC5 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |